obesity

Keyword: obesity

59 results found

Canadian employers are increasingly focusing on coverage for women’s health and gender affirmation in their employee benefits plans, according to a new survey by WTW. The survey, which polled more than 100 employers, found half (49 per cent) of organizations reported women’s health as a top or high priority. To that end, two-fifths (39 per […]

  • By: Staff
  • February 11, 2025 February 10, 2025
  • 09:00

A third (33 per cent) of U.S. employers currently include cell and gene therapies in their benefits plans and 36 per cent are actively evaluating the use of these treatments, according to a new survey by the Integrated Benefits Institute. The survey, which polled more than 400 U.S. employers and more than 200 benefits consultants, […]

  • By: Staff
  • January 28, 2025 January 28, 2025
  • 14:30

A majority (65 per cent) of Canadian employers say they have or are working on implementing a diversity, equity and inclusion policy, while 44 per cent of this group said they’re focusing on DEI to attract and retain employees, according to Benefits Canada’s 2024 Future of Work Survey. It found around three-quarters (72 per cent) […]

  • By: Blake Wolfe
  • January 27, 2025 January 15, 2025
  • 07:55

Women face unique health challenges throughout their lives — across most age groups, women experience higher rates of chronic diseases compared to men, said Neda Nasseri, pharmacist and product director of drug benefits at Desjardins Insurance, during a session supported by Pfizer Canada at Benefits Canada’s 2024 Face to Face Drug Plan Management Forum. Historically, […]

Advances in medical science and innovations in drug development necessitate updated drug plan strategies, according to Frédéric Leblanc (pictured far right), strategic leader of drug programs, group benefits and retirement solutions at iA Financial Group. During a panel discussion supported by EMD Serono Inc., GSK, iA Financial Group, Merck & Co. Inc., Novo Nordisk Canada Inc. […]

Copyright_markovsergei_123RF

The previous year was an interesting one in the world of employee benefits plans. Over the previous 12 months, employers have navigated the explosion of claims for glucagon-like peptide-1 receptor agonist medications like Ozempic, some forward momentum on national pharmacare and some employers changed their approach to diversity, equity and inclusion policies. Here are five […]

  • By: Kim Siddall
  • January 21, 2025 January 21, 2025
  • 09:00
Copyright_skorzewiak_123RF

From the unlocking of pension benefits in Nova Scotia to new pay transparency rules in Ontario, stories about pension and employment legislation caught the eyes of Benefits Canada’s readers in 2024. In addition, a pair of articles on the rollout of new glucagon-like peptide-1 receptor agonist medications in Canada were also popular with readers. Here […]

  • By: Staff
  • December 23, 2024 December 19, 2024
  • 09:00

Between 2019 and 2023, chronic disease drug claims increased much faster among younger plan members compared to older generations, according to a new report by Sun Life. The report, which analyzed drug claims data of more than 3 million plan members over a five-year period, found across all age groups, nearly half (45.1 per cent) of […]

  • By: Staff
  • December 19, 2024 December 18, 2024
  • 09:00

Treating obesity with all available evidence-based tools ultimately costs less than not treating it, according to panellists during a webinar hosted by Benefits Canada and sponsored by Eli Lilly Canada Inc. in collaboration with Obesity Canada. Dr. Akshay Jain (pictured right), a clinical and research endocrinologist, provided an overview of obesity — a chronic, progressive, […]

Copyright_ilixe48_123RF

An article on employees’ views of employer-sponsored benefits plans was the most-read story on BenefitsCanada.com this past week. Here are the top five human resources, benefits, pension and investment stories of the last week: 1. Survey finds seven in 10 Canadian workers dissatisfied with their employer’s benefits plan 2. Claims for obesity, diabetes medications up in 2023: […]

  • By: Staff
  • November 29, 2024 November 28, 2024
  • 09:00